AzTrials
AzTrials

Hypomineralized Second Primary MolarsNCT06753695

Prevalence of Hypomineralized Second Primary Molars and Their Association with Dental Hypersensitivity in Egyptian Children

An observational study of Hypomineralized Second Primary Molars and Dental Hypersensitivity, run by Cairo University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

hypomineralized second primary molars and dental hypersensitivity in a group of Egyptian children Read more about this study

Who is it for?
Ages 4 to 9 yearsHealthy volunteers can take part
How many people
825 participants
Where
No sites listed yet
Study dates
Mar 2025to Apr 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 9 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: a group of gentian children aged form4 to 9 years old

Who may be able to join

  • Egyptian children
  • cooperative patients both genders and included 4-9 years old children at least one HSPM affected molar and one non affected molar absence of syndromes or craniofacial anomalies

Who cannot join

  • other developmental defects(amelogensis imperfecta ...) children ongoing anti-inflammatory drugs children who caregiver will not sign the informed consent

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Prevalence of Hypomineralized Second Primary Molars(HSPM) and Its Association with Dental Hypersensitivity in a Group of Egyptian Children: a Cross-sectional Study.

hypomineralized second primary molars and dental hypersensitivity in a group of Egyptian children

Read the detailed description

the prevalence of the condition of hypomineralized second primary molars in a group of Egyptian children and the association of this condition to dental hypersensitivity.

Keywords
HSPM, DH, hypo-mineralized second primary molars, hypomineralized E

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. EAPD scoring criteria and wurzberg scroring system

    present/absent of the condition

    Measured: 1 year

Secondary outcomes (1)
  1. VAS scale and SCASS scale

    measuring dental hypersensitivity using VAS scale and SCASS scale to reach for an association of dental hypersensitivity and HSPM

    Measured: 1year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Dec 2024
  2. Study startMar 2025 (estimated)
  3. Primary completionMar 2025 (estimated)
  4. Study completionApr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
825 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06753695
Sponsor's protocol ID
HSPM-DH-EG-2024
Status last verified
Dec 2024
First submitted
23 Dec 2024
Last updated
31 Dec 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Hypomineralized Second Primary Molars and Dental Hypersensitivity, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 31 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Aya M Ibrahim, B.D.S. (+2001003396390, aya.mamdouh@dentistry.edu.cu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

EAPD scoring criteria and wurzberg scroring system (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in